Automated Reminders for Colorectal Cancer Screening
Trial Summary
What is the purpose of this trial?
The investigators will expand an existing, patient-centered, health literacy strategy to promote longer-term adherence to colorectal cancer (CRC) screening in resource-limited, rural health clinics via colonoscopy or annual fecal immunochemical test (FIT). In the proposed 2-arm study, both PRIME-CRC and enhanced usual care (control) will incorporate health literacy evidence-based practices for delivering CRC patient information and counseling to aid patient decision making for selecting FIT or colonoscopy, including simplified test instructions. In addition, the PRIME-CRC arm will use a "stepped care" approach for reminding patients on proper CRC screening preparation for scheduled colonoscopy or completion of annual FIT. Patients in the PRIME-CRC arm will receive frequent follow-up contact from their health care provider via audio-recorded, automated call or SMS text, based on patient preference.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the trial focuses on reminders for colorectal cancer screening.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on promoting colorectal cancer screening and does not mention medication changes.
What data supports the idea that Automated Reminders for Colorectal Cancer Screening is an effective treatment?
The available research shows that using simple, easy-to-understand instructions, like wordless instructions, can help increase colorectal cancer screening rates among people with low literacy or those who don't speak English. This suggests that clear communication, similar to automated reminders, can be effective in encouraging people to complete screenings. Additionally, while the research doesn't directly address automated reminders, it highlights the importance of health literacy in screening participation, which automated reminders can help improve by providing clear and timely information.12345
What data supports the effectiveness of the treatment Automated Reminders for Colorectal Cancer Screening?
Research shows that using simple, low-literacy instructions can help increase colorectal cancer screening rates, especially among people with low literacy or non-English speakers. Additionally, computer-assisted education programs have been effective in helping patients understand health information better than traditional brochures, suggesting that automated reminders could similarly improve understanding and participation in screenings.12345
What safety data exists for automated reminders for colorectal cancer screening?
The provided research does not directly address safety data for automated reminders for colorectal cancer screening. The studies focus on health literacy, patient education, and decision-making related to colorectal cancer screening, but do not evaluate the safety of automated reminders like calls or texts. Further research specifically targeting the safety of these automated reminder systems would be needed to provide a comprehensive answer.12467
Is it safe to use automated reminders for colorectal cancer screening?
Is the treatment in the trial 'Automated Reminders for Colorectal Cancer Screening' a promising treatment?
Yes, the treatment is promising because it can help increase colorectal cancer screening rates by using automated reminders. This approach can make it easier for people to remember to get screened, especially those who might forget or not know when to do it. By improving screening rates, it can help catch cancer early, which is important for successful treatment.12358
How does the treatment of automated reminders for colorectal cancer screening differ from other treatments?
Automated reminders for colorectal cancer screening are unique because they focus on improving patient participation through reminders, rather than directly treating the condition. This approach is different from traditional treatments, as it aims to increase screening rates by addressing barriers like low literacy and patient perceptions, rather than using medical interventions.12358
Research Team
Connie L Arnold, PhD
Principal Investigator
LSU Health Sciences Center Shreveport
Eligibility Criteria
The PRIME-CRC Trial is for English-speaking individuals aged 45 to 75 who have visited participating rural health clinics in the past year. It's not for those up-to-date with CRC screening, very ill patients, or those with cognitive impairments, significant hearing or vision issues, a family history requiring different screening due to risk factors, or a history of cancer other than non-melanoma skin cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive patient-centered reminders and health literacy education to promote CRC screening adherence via colonoscopy or annual FIT
Follow-up
Participants are monitored for completion of CRC screening and adherence to screening guidelines
Treatment Details
Interventions
- automated call reminders or automated texts
- health literacy appropriate education and demonstration
- shared decision making
Find a Clinic Near You
Who Is Running the Clinical Trial?
Louisiana State University Health Sciences Center Shreveport
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Northwestern University
Collaborator